Files in this item
Acetylation site specificities of lysine deacetylase inhibitors in human cells
Item metadata
dc.contributor.author | Schölz, Christian | |
dc.contributor.author | Weinert, Brian T. | |
dc.contributor.author | Wagner, Sebastian A. | |
dc.contributor.author | Beli, Petra | |
dc.contributor.author | Miyake, Yasuyuki | |
dc.contributor.author | Qi, Yun | |
dc.contributor.author | Jensen, Lars J. | |
dc.contributor.author | Streicher, Werner | |
dc.contributor.author | McCarthy, Anna Rose | |
dc.contributor.author | Westwood, Nicholas James | |
dc.contributor.author | Lain, Sonya | |
dc.contributor.author | Cox, Jürgen | |
dc.contributor.author | Matthias, Patrick | |
dc.contributor.author | Mann, Matthias | |
dc.contributor.author | Bradner, James E. | |
dc.contributor.author | Choudhary, Chunaram | |
dc.date.accessioned | 2015-09-08T23:10:53Z | |
dc.date.available | 2015-09-08T23:10:53Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Schölz , C , Weinert , B T , Wagner , S A , Beli , P , Miyake , Y , Qi , Y , Jensen , L J , Streicher , W , McCarthy , A R , Westwood , N J , Lain , S , Cox , J , Matthias , P , Mann , M , Bradner , J E & Choudhary , C 2015 , ' Acetylation site specificities of lysine deacetylase inhibitors in human cells ' , Nature Biotechnology . https://doi.org/10.1038/nbt.3130 | en |
dc.identifier.issn | 1087-0156 | |
dc.identifier.other | PURE: 159921200 | |
dc.identifier.other | PURE UUID: 5d3afdc5-779e-48af-8ada-079f500d1966 | |
dc.identifier.other | Scopus: 84926614325 | |
dc.identifier.other | ORCID: /0000-0003-0630-0138/work/56424175 | |
dc.identifier.other | WOS: 000352348500029 | |
dc.identifier.uri | https://hdl.handle.net/10023/7421 | |
dc.description | This work was supported by the Hallas Møller Investigator grant from the Novo Nordisk Foundation to C.C. S.A.W. and P.B. were supported by individual postdoctoral grants from the Danish Research Council (FSS: 10-085134, FSS: 12-12610). C.C. is supported by the EMBO Young Investigator program. J.E.B. is supported by a grant from the Doris Duke Charitable Foundation. | en |
dc.description.abstract | Lysine deacetylases inhibitors (KDACIs) are used in basic research, and many are being investigated in clinical trials for treatment of cancer and other diseases. However, their specificities in cells are incompletely characterized. Here we used quantitative mass spectrometry (MS) to obtain acetylation signatures for 19 different KDACIs, covering all 18 human lysine deacetylases. Most KDACIs increased acetylation of a small, specific subset of the acetylome, including sites on histones and other chromatin-associated proteins. Inhibitor treatment combined with genetic deletion showed that the effects of the pan-sirtuin inhibitor nicotinamide are primarily mediated by SIRT1 inhibition. Furthermore, we confirmed that the effects of tubacin and bufexamac on cytoplasmic proteins result from inhibition of HDAC6. Bufexamac also triggered an HDAC6-independent, hypoxia-like response by stabilizing HIF1-α, providing a possible mechanistic explanation of its adverse, pro-inflammatory effects. Our results offer a systems view of KDACI specificities, providing a framework for studying function of acetylation and deacetylases. | |
dc.language.iso | eng | |
dc.relation.ispartof | Nature Biotechnology | en |
dc.rights | Copyright 2015 the Authors. This work is made available online in accordance with the publisher’s policies. This is the author created, accepted version manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at http://doi.org/10.1038/nbt.3130 | en |
dc.subject | Acetylation | en |
dc.subject | Deacetylase inhibitor | en |
dc.subject | SILAC | en |
dc.subject | HDAC | en |
dc.subject | KDAC | en |
dc.subject | Mass spectrometry | en |
dc.subject | Proteomics | en |
dc.subject | Sirtuin | en |
dc.subject | Nicotinamide | en |
dc.subject | Tenovin-6 | en |
dc.subject | Bufexamac | en |
dc.subject | QD Chemistry | en |
dc.subject | DAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | QD | en |
dc.title | Acetylation site specificities of lysine deacetylase inhibitors in human cells | en |
dc.type | Journal article | en |
dc.description.version | Postprint | en |
dc.contributor.institution | University of St Andrews. School of Chemistry | en |
dc.contributor.institution | University of St Andrews. EaSTCHEM | en |
dc.contributor.institution | University of St Andrews. Biomedical Sciences Research Complex | en |
dc.identifier.doi | https://doi.org/10.1038/nbt.3130 | |
dc.description.status | Peer reviewed | en |
dc.date.embargoedUntil | 2015-09-09 | |
dc.identifier.url | http://www.nature.com/nbt/journal/vaop/ncurrent/full/nbt.3130.html#supplementary-information | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.